Detalhe da pesquisa
1.
Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors.
Nat Immunol
; 24(8): 1345-1357, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37400675
2.
Author Correction: Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors.
Nat Immunol
; 24(8): 1391, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37464051
3.
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer.
Sci Transl Med
; 16(736): eabj9905, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416845
4.
Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells.
JCI Insight
; 8(2)2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512410
5.
Linked CD4 + /CD8 + T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.
bioRxiv
; 2023 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205330
6.
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.
J Clin Invest
; 133(17)2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37655661
7.
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.
Sci Rep
; 12(1): 16860, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36258023
8.
Harnessing neoantigen specific CD4 T cells for cancer immunotherapy.
J Leukoc Biol
; 107(4): 625-633, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170883
9.
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
Vaccine
; 37(1): 80-89, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478007